FOLR1 and neoplasm: By selecting for high specificity, i.e., low off-target binding and reduced on-target off-tumor binding, we identified three candidates (anti-FOLR1 scFv-Fc 12, 14, and 19) with a staining profile similar to the established anti-FOLR1 positive reference antibody.